Innovative Approaches to Cancer Acquired Resistance: Precision Immuno- Oncology and Synthetic Immune Lethality

Time: 12:30 pm
day: Conference Day Two


  • Exploring how a combination of synthetic lethality with immunotherapy could form a new class of treatments to tackle acquired resistance in cancers.
  • Reviewing how these approaches hold significant potential in improving response rates and survival in cancer patients